Zika virus specific diagnostic epitope discovery

Journal of Visualized Experiments

Volumn 2017, Issue 130, 2017, Pages

  Sabalza, Maite ^a   Barber, Cheryl A ^a   Abrams, William R ^a   Montagna, Richard ^b   Malamud, Daniel ^a,c  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b Rheonix Inc Inc   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnostic peptides; High throughput screening; IgG; IgM; Immunoassay; Immunology; Issue 130; Microarray; Zika

Indexed keywords

EPITOPE; VIRUS ANTIBODY;

HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIROLOGY; ZIKA FEVER; ZIKA VIRUS;

ANTIBODIES, VIRAL; EPITOPES; HUMANS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85037636704     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/56784     Document Type: Article

References (19)

1. Kelser, E. A. Meet dengue’s cousin, Zika. Microbes Infect. 18 (3), 163-166 (2016).
2. Musso, D. et al. Detection of Zika virus in saliva. J Clin Virol. 68 53-55 (2015).
3. Siqueira, W. L. et al. Oral Clinical Manifestations of Patients Infected with Zika Virus. Oral Health. December (2016).
4. Duarte, G. Challenges of Zika Virus Infection in Pregnant Women. Rev Bras Ginecol Obstet. 38 (6), 263-265 (2016).
5. Buus, S. et al. High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays. Mol Cell Proteomics. 11 (12), 1790-1800 (2012).
6. Kouzmitcheva, G. A., Petrenko, V. A., & Smith, G. P. Identifying diagnostic peptides for lyme disease through epitope discovery. Clin Diagn Lab Immunol. 8 (1), 150-160 (2001).
7. Hamby, C. V., Llibre, M., Utpat, S., & Wormser, G. P. Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera. Clin Diagn Lab Immunol. 12 (7), 801-807 (2005).
8. t Hoen, P. A. et al. Phage display screening without repetitious selection rounds. Anal Biochem. 421 (2), 622-631 (2012).
9. Townend, J. E., & Tavassoli, A. Traceless Production of Cyclic Peptide Libraries in E. coli. ACS Chem Biol. 11 (6), 1624-1630 (2016).
10. Turchetto, J. et al. High-throughput expression of animal venom toxins in Escherichia coli to generate a large library of oxidized disulphidereticulated peptides for drug discovery. Microbial Cell Factories. 16 (1), 6 (2017).
11. Carmona, S. J., Sartor, P. A., Leguizamon, M. S., Campetella, O. E., & Aguero, F. Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features. Plos One. 7 (12), e50748 (2012).
12. Lagatie, O., Van Dorst, B., & Stuyver, L. J. Identification of three immunodominant motifs with atypical isotype profile scattered over the Onchocerca volvulus proteome. PLoS Negl Trop Dis. 11 (1), e0005330 (2017).
13. Basile, A. J. Development and validation of an ELISA kit (YF MAC-HD) to detect IgM to yellow fever virus. J Virol Methods. 225 41-48 (2015).
14. Madden, T. The BLAST Sequence Analysis Tool. The NCBI Handbook [Internet]. 2nd edition. (2013).
15. Services, U. S. D. o. H. a. H. Biosafety in Microbiological and Biomedical Laboratories (BMBL). 5th edn, Vol. HHS Publication No. (CDC) 21-1112 (2009).
16. Pellois, J. P. et al. Individually addressable parallel peptide synthesis on microchips. Nat Biotech. 20 (9), 922-926 (2002).
17. Stafford, P. et al. Physical Characterization of the “Immunosignaturing Effect”. Mol Cell Proteomics. 11 (4) (2012).
18. Gardner, T. J. et al. Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein. Nat Commun. 7 (2016).
19. Nixon, C. E. et al. Identification of protective B-cell epitopes within the novel malaria vaccine candidate P. falciparum Schizont Egress Antigen-1. Clin Vaccine Immunol. (2017).